SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Adial Pharmaceuticals, Inc. ADIL NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Adial Pharmaceuticals, Inc. (ADIL) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ADTX, AEZS, ALRN, AMTI, ATXI, AXLA 等.

ADIL 的市值为 $1.55M, 而同行平均市值为 $84.5M. ADIL 显著小于其平均同行.

同行与相似公司 — ADIL

$0.45 +6.15% $1.2K

Aeterna Zentaris Inc.

$5.72 +2.14% $17.51M

Aileron Therapeutics, Inc.

$2.11 +9.33% $45.72M

Applied Molecular Transport Inc.

$0.26 -3.13% $11.01M

Avenue Therapeutics, Inc.

$0.51 +14.17% $1.68M

Axcella Health Inc.

$4.58 0.00% $12.5M

Benitec Biopharma Inc.

$13.60 +2.64% $356.96M

Bio-Path Holdings, Inc.

$0.06 +0.80% $587.62K

Better Therapeutics, Inc.

$0.00 0.00% $5.45K

Catalyst Biosciences, Inc.

$19.95 +2.20% $549.76M

Diffusion Pharmaceuticals Inc.

$4.40 +10.28% $8.98M

Hoth Therapeutics, Inc.

$0.70 +7.93% $9.24M

其他人也在看

Catalyst Biosciences, Inc.

Benitec Biopharma Inc.

Tonix Pharmaceuticals Holding Corp.

Aileron Therapeutics, Inc.

Onconova Therapeutics, Inc.

NeuroBo Pharmaceuticals, Inc.

Aeterna Zentaris Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言